CMO

Partner Content

Partner Content

The bar is set high for Medical Affairs (MA) talent: traditional capabilities are no longer sufficient to address

News

MSD's TROP2-targeting antibody-drug conjugate sac-TMT, licensed from China's Kelun, has improved survival in a late-stage endometrial cancer trial.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.